Next Article in Journal
EML4-ALK Variants: Biological and Molecular Properties, and the Implications for Patients
Next Article in Special Issue
Reduced Cytokine Release in Ex Vivo Response to Cilengitide and Cetuximab Is a Marker for Improved Survival of Head and Neck Cancer Patients
Previous Article in Journal
Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM)
Previous Article in Special Issue
Integrins as Therapeutic Targets: Successes and Cancers
 
 
Review

Article Versions Notes

Action Date Notes Link
article pdf uploaded. 4 September 2017 16:00 CEST Version of Record https://www.mdpi.com/2072-6694/9/9/116/pdf
article xml uploaded. 4 September 2017 16:00 CEST Original file https://www.mdpi.com/2072-6694/9/9/116/xml
article html file updated 4 September 2017 16:01 CEST Original file -
article html file updated 30 September 2017 10:16 CEST Update -
article html file updated 3 May 2019 03:37 CEST Update -
article html file updated 26 September 2019 22:43 CEST Update -
article html file updated 8 February 2020 15:18 CET Update -
article html file updated 16 July 2022 06:10 CEST Update https://www.mdpi.com/2072-6694/9/9/116/html
Back to TopTop